CorMedix Inc reports results for the quarter ended in December - Earnings Summary

CorMedix

30/03/2023 14:31

* CorMedix Inc  CRMD.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in December. The mean
expectation of three analysts for the quarter was for a loss
of 19 cents per share.
    * Revenue fell 48.6% to $29.00 thousand from a year ago;
analysts
expected $2.33 thousand. 
    * CorMedix Inc's reported EPS for the quarter was a loss
of 20
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * CorMedix Inc shares had fallen by 13.3% this quarter.
    * The company reported a quarterly loss of $8.21 million.
    * Wall Street's median 12-month price target for CorMedix
Inc is
$16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 30 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.19          -0.20          Missed
 Sep. 30 2022      -0.23          -0.17          Beat
 Jun. 30 2022      -0.21          -0.19          Beat
 Mar. 31 2022      -0.22          -0.18          Beat